1.
Tavakoli M, Pirayesh E, Khoshbakht S, Javan Shayani P, Ghodsi Rad MA, Amoui M. Assessment of Neuroendocrine Features Using 99mTc-Octreotide Scintigraphy in Patients with Metastatic Castration-Resistant Prostate Cancer: Does it Predict Response to 177Lu-PSMA Radioligand Therapy?. Urol J [Internet]. 2026 Aug. 29 [cited 2026 Sep. 6];23(03):100-6. Available from: https://journals.sbmu.ac.ir/urolj/index.php/uj/article/view/8610